Production (Stage)
Bicycle Therapeutics plc
BCYC
$8.05
-$0.05-0.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -128.72% | -5.61% | -1.81% | 6.55% | 32.00% |
| Total Depreciation and Amortization | -1.45% | 3.02% | 28.52% | -0.30% | 6.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.83% | -41.79% | -46.75% | 37.98% | 22.46% |
| Change in Net Operating Assets | 34.89% | 542.06% | -97.16% | -123.00% | -242.38% |
| Cash from Operations | -21.87% | 80.13% | -3,786.05% | -230.89% | -52.70% |
| Capital Expenditure | -4,933.33% | -621.57% | 13.35% | -51.62% | 99.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,933.33% | -621.57% | 13.35% | -51.62% | 99.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.89% | -36.53% | -- | 4,371.25% | -31.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.19% | -47.41% | -113.61% | 4,371.25% | -31.16% |
| Foreign Exchange rate Adjustments | 212.50% | -238.17% | 287.71% | -137.87% | -191.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.66% | 75.16% | -130.36% | 981.91% | -53.13% |